학술논문
A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models
Document Type
Article
Author
Source
In: Frontiers in Immunology . (Frontiers in Immunology, 2023, 14)
Subject
Language
English
ISSN
16643224